Molecule
PrivateLast Round
Strategic
Dec 11, 2023
Total Funding Raised
$13.7M
Company Overview
Molecule is a biotechnology and web3 company that operates a decentralized marketplace to connect researchers with funding for scientific and drug development projects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Tokenization, DAOs, Blockchain Infrastructure
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule Comparables
Compare Molecule with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bio Protocol | 92% | |
| Bioneex | 71% | |
| AminoChain | 70% |
Molecule Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 11, 2023 | ||||
| Seed | Jun 27, 2022 | ||||
| Pre Seed | Jan 31, 2020 | ||||
| Pre Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
Molecule Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Seed |
| Backed VC | Seed |
| Inflection | Pre Seed, Seed |
| ID Theory | Pre Seed, Seed |
| First Principles | Pre Seed, Seed |
| L1 Digital | Seed |
| Orange DAO | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2025
Added ResearchHub, a scientific research startup, as a customer.
- Sep 30, 2025
Added Biome as a new customer.
Molecule Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Molecule's valuation, stock price, and market status.
Is Molecule a public or private company?
Molecule is a private company.
What is the current stock price of Molecule?
Molecule is a private company with no public stock price. No recent secondary market data is available.
How much is Molecule worth (valuation)?
Valuation information for Molecule is not publicly available.
Can I buy Molecule stock?
Molecule shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Molecule's last funding round?
Molecule's most recent funding round was Strategic on December 8, 2023.
Who are the main investors in Molecule?
Key investors in Molecule include Northpond Ventures, Sora Ventures, Lunar Ventures.
Will Molecule IPO soon?
No public IPO plans have been announced for Molecule.
How can I track Molecule secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecule's secondary market activity and sign up for updates.